{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:54:52Z","timestamp":1792076092902,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.msard.2020.102439","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T13:42:03Z","timestamp":1596289323000},"page":"102439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["Effects of MS disease-modifying therapies on responses to vaccinations: A review."],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-8841","authenticated-orcid":false,"given":"John Robert","family":"Ciotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouela V.","family":"Valtcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-7569","authenticated-orcid":false,"given":"Anne Haney","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.msard.2020.102439_bib0001","doi-asserted-by":"crossref","first-page":"E1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102439_bib0002","doi-asserted-by":"crossref","unstructured":"Clem A.S.Fundamentals of vaccine immunology. In: J. Glob. Infect. Dis.. Vol 3.; 2011:73\u201378. doi:10.4103\/0974-777X.77299.","DOI":"10.4103\/0974-777X.77299"},{"key":"10.1016\/j.msard.2020.102439_bib0003","first-page":"327","article-title":"Measuring vaccine responses in the multiplex era.","volume":"2018","author":"Ayling","year":"1781"},{"issue":"3","key":"10.1016\/j.msard.2020.102439_bib0004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CVI.00613-15","article-title":"Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories","volume":"23","author":"Zacour","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.msard.2020.102439_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and Gender Differences in the Outcomes of Vaccination over the Life Course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.msard.2020.102439_bib0006","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2020.102439_bib0007","series-title":"Adverse Effects of Vaccines: Evidence and Causality","author":"Stratton","year":"2012"},{"issue":"7","key":"10.1016\/j.msard.2020.102439_bib0008","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.56.7.938","article-title":"Influenza vaccination in MS: absence of T-cell response against white matter proteins","volume":"56","author":"Moriabadi","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102439_bib0009","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis","volume":"48","author":"Miller","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102439_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.2014.16946","article-title":"Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system","volume":"313","author":"Scheller","year":"2015","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102439_bib0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2011.10.013","article-title":"Seasonal and H1N1v influenza vaccines in MS: safety and compliance","volume":"314","author":"Auriel","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2020.102439_bib0012","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group","volume":"344","author":"Confavreux","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.msard.2020.102439_bib0013","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2020.102439_bib0014","unstructured":"ACIP Altered Immunocompetence Guidelines for Immunizations | Recommendations | CDC. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html#t-01."},{"key":"10.1016\/j.msard.2020.102439_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.msard.2019.04.004","article-title":"Immunization and multiple sclerosis: recommendations from the French multiple sclerosis society","volume":"31","author":"Lebrun","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2020.102439_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy174","article-title":"Infectious Complications of Multiple Sclerosis Therapies: implications for Screening, Prophylaxis, and Management","volume":"5","author":"Epstein","year":"2018","journal-title":"Open forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.msard.2020.102439_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneurol.2012.8","article-title":"Vaccination against infection in patients with multiple sclerosis","volume":"8","author":"Loebermann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2020.102439_bib0018","unstructured":"OCEBM Levels of Evidence - CEBM. https:\/\/www.cebm.net\/2016\/05\/ocebm-levels-of-evidence\/."},{"issue":"12","key":"10.1016\/j.msard.2020.102439_bib0019","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/01.wnl.0000188901.12700.e0","article-title":"Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a","volume":"65","author":"Schwid","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2020.102439_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.0b013e31829e6fbf","article-title":"Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis","volume":"81","author":"Bar-Or","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2020.102439_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078532","article-title":"Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFN\u03b2-therapy","volume":"8","author":"Mehling","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.msard.2020.102439_bib0022","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/1352458513513970","article-title":"Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study","volume":"20","author":"Olberg","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"3","key":"10.1016\/j.msard.2020.102439_bib0023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ene.13537","article-title":"Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy","volume":"25","author":"Olberg","year":"2018","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.msard.2020.102439_bib0024","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000409","article-title":"Immune response to vaccines is maintained in patients treated with dimethyl fumarate","volume":"5","author":"Von Hehn","year":"2018","journal-title":"Neurol. Neuroimmunol. NeuroInflammation."},{"issue":"2","key":"10.1016\/j.msard.2020.102439_bib0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cns.13034","article-title":"Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies","volume":"25","author":"Metze","year":"2019","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.msard.2020.102439_bib0026","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/NXI.0000000000000070","article-title":"Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens","volume":"2","author":"Bar-Or","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"issue":"2","key":"10.1016\/j.msard.2020.102439_bib0027","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.22352","article-title":"Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients","volume":"69","author":"Mehling","year":"2011","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2020.102439_bib0028","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.0000000000001302","article-title":"Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis","volume":"84","author":"Kappos","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2020.102439_bib0029","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1212\/NXI.0000000000000398","article-title":"Impact of siponimod on vaccination response in a randomized, placebo-controlled study","volume":"4","author":"Ufer","year":"2017","journal-title":"Neurol. Neuroimmunol. neuroinflammation"},{"issue":"7","key":"10.1016\/j.msard.2020.102439_bib0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1179\/1743132812Y.0000000059","article-title":"Humoral immune response to influenza vaccine in natalizumab-treated MS patients","volume":"34","author":"V\u00e5gberg","year":"2012","journal-title":"Neurol. Res."},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102439_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2014.03.035","article-title":"Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis","volume":"341","author":"Kaufman","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"15 Supplement","key":"10.1016\/j.msard.2020.102439_bib0032","article-title":"Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis (S36.002)","volume":"90","author":"Stokmaier","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102439_bib0033","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.msard.2020.102439_bib0034","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.0b013e3182a35215","article-title":"Immune competence after alemtuzumab treatment of multiple sclerosis","volume":"81","author":"McCarthy","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102439_bib0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-92-4-471","article-title":"Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses","volume":"92","author":"Briggs","year":"1980","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.msard.2020.102439_bib0036","first-page":"289","article-title":"Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma","volume":"70","author":"Lahood","year":"1993","journal-title":"Ann. Allergy"},{"issue":"2","key":"10.1016\/j.msard.2020.102439_bib0037","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338043","article-title":"Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus","volume":"34","author":"Elkayam","year":"2002","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.msard.2020.102439_bib0038","unstructured":"Wallin L., Quintilio W., Locatelli F., Cassel A., Silva M.B., Skare T.L. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients. Acta Reumatol. Port.. 34(3):498\u2013502."},{"issue":"3","key":"10.1016\/j.msard.2020.102439_bib0039","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2020.102439_bib0040","unstructured":"Draft landscape of COVID-19 candidate vaccines. Accessed June26, 2020. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820305149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820305149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:55:02Z","timestamp":1761900902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820305149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":40,"alternative-id":["S2211034820305149"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102439","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of MS disease-modifying therapies on responses to vaccinations: A review.","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102439"}}